this week, @elilillyandcompany.bsky.social became the first $1T drugmaker thanks to its success developing obesity and diabetes medicines that have become household names. from @nedpagliarulo.bsky.social (!) + @byjongardner.bsky.social for @biopharmadive.com www.biopharmadive.com/news/eli-lil...

in a switch-up for Zymeworks, the cancer drugmaker is pursuing a royalty-based model after a data readout that suggests its medicines could be future blockbusters: www.biopharmadive.com/news/zymewor...

Purdue to the rescue of IU student newspaper, whose institution was attempting censorship. Details in alt!

A new target for colorectal cancer is the focus of #biosky biotech Cartography's lead program. “There’s still an opportunity to build the right molecule,” CEO Kevin Parker told @biopharmadive.com www.biopharmadive.com/news/cartogr...

must-read from my colleague Jacob Bell on the how cancer pain meds haven't progressed much past opioids, and why that is: www.biopharmadive.com/news/cancer-... #biosky

Schizophrenia drug developer LB Pharmaceuticals priced the first major biotech IPO since February, selling more shares than originally forecast #biosky www.biopharmadive.com/news/lb-phar...

This is telling: People I spoke to are talking about CDC in the past tense. www.statnews.com/2025/08/28/c...

The Department of Health and Human Services is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the biomedical sciences. www.statnews.com/2025/08/25/n...

From WSJ's story last night on Intel & the White House (gift link to story is also below) www.wsj.com/tech/inside-...

Took a step out of biotech startup reporting today - Ionis Pharmaceuticals got approval from the FDA today for its hereditary angiodema drug Dawnzera. Its list price: $57,642 per dose. www.biopharmadive.com/news/ionis-d...

latest from the @biopharmadive.com team - researchers and investors weigh in on how cuts to mRNA research may make the U.S. fall behind other countries #biosky www.biopharmadive.com/news/mrna-va...

Today, we sent a letter to @themarshallproject.org‬ leadership expressing concern about their denial of bargaining obligations. Management has repeatedly denied members Weingarten rights, engaged in an illegal layoff, and more — we need your help to demand that management bargain in good faith.

In the latest move to get rid of "zombie" biotechs, Xoma Royalty will acquire HilleVax and Lava Therapeutics, two companies that have struggled since clinical testing of their lead drug candidates failed last year:. #biosky www.biopharmadive.com/news/xoma-hi...

"A region known for its seemingly endless summer is still awaiting the end of the biotech winter that has swept up much of the industry." My latest for @statnews.com on the state of biotech in San Diego www.statnews.com/2025/08/04/s...

This is a really well-written profile, and worth the time to read. There's also a line that immediately made my eyes water: www.washingtonpost.com/parenting/in...

In a video appearance with an immigration judge, a detainee pulled out a jar of bright red blood and set it on the table in front of him. Many of the people in the courtroom gasped in unison. “I have cancer. This is the blood I’ve lost today.” capitalandmain.com/with-a-jar-o...

Targeted protein degradation has been a huge focus of #biosky and investors over the past decade. I dove into why for @biopharmadive.com: www.biopharmadive.com/news/protein...

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say endpoints.news/sources-fda-...

Houston police called ICE on a woman who called 911 to report domestic abuse by her ex-husband. The only reason she didn't get deported is because ICE said there was no one to take custody of her kids, according to the police report. www.houstonchronicle.com/news/houston...

“Recent policy changes around COVID-19 vaccines are already sowing chaos and confusion and restricting vaccine access — including for people who should still be eligible to receive them.” I wrote about RFK Jr’s anti-vax chaos for @thesicktimes.bsky.social. thesicktimes.org/2025/06/19/t...

EXCLUSIVE: The ouster of Nicole Verdun, the FDA's chief regulator of cell and gene therapies, came after disagreements over the review of Capricor's Duchenne therapy. At the same time, some have taken issue with Verdun's management style. Details below: www.statnews.com/2025/06/20/f...

A dismal investment climate for publicly traded biotech companies is causing startups and their backers to tighten their belts, investors and analysts say. Latest for @biopharmadive.com #biosky www.biopharmadive.com/news/biotech...

Before RFK Jr. announced healthy children no longer need coronavirus vaccines, the CDC’s data showed more than half of young children admitted to the ICU for covid had no underlying conditions wapo.st/4kk4DlE

Good reporting from @nbcnews.com: As use of dietary supplements grow, so do rates of liver injuries. Most people who take dietary or herbal supplements do so on their own, not under a doctor’s advice. www.nbcnews.com/health/healt...

Eric Licas is such an intrepid reporter whose Orange County stories reached wide audiences with no engagement help from the LA Times parent company, which noticed him for a layoff amid their financial troubles. Your news organization would be blessed to have him.

🧵I counseled sexual assault survivors for many years at a crisis center; I've been an advocate and activist in that space since high school. And this is what every rapist thinks: "I have far more at stake and to lose than any other source in this piece." Always.

Some of y’all noticed I’ve been uncharacteristically offline. This is why, and I remain on leave for a few weeks to handle a PTSD relapse. CJR was dogged in its pursuit of my story. Because of what I do and who I am, I felt that I had to answer their questions honestly. www.cjr.org/feature-2/we...

Ozempic maker @novonordisk.bsky.social is taking another step toward finding an oral obesity drug, this time with a deal with Bay Area biotech Septerna: www.biopharmadive.com/news/novo-no...

Things are changing so fast at the FDA that when I emailed a trade group for comment on a policy announced yesterday morning, they sent me an answer about the new policy from the day before. Here's a humble attempt to tally up the way these changes might affect drug dev: cen.acs.org/pharmaceutic...

"Scoops don’t drop out of the sky; they’re a result of building relationships and trust with people who have a lot to lose by telling the truth. Not crediting my work isn’t just an insult to me, but to my sources who took a risk by choosing to share information with me."

hey! wanna do something meaningful this asian american and pacific islander heritage month? how about following and sharing this asian american journalists association members starter pack?

Siren Biotechnology is taking a page out of Silicon Valley's startup playbook: crowdfunding an investment round. "The scientist in me is just like, 'We’re going to run this experiment and see if it works.'" #biosky For @biopharmadive.com: www.biopharmadive.com/news/siren-b...

Today the Supreme Court hears arguments in a key case that could determine whether insurers must cover certain preventive care, like cancer screenings and statins. @anguschen.bsky.social clearly explains the stakes on this challenge to the Affordable Care Act: www.statnews.com/2025/04/17/k...

@houstonlanding.bsky.social is closing: talkingbiznews.com/media-moves/...

Palestinian Columbia University student Mohsen Mahdawi, a leader of the campus anti-genocide movement, was detained for deportation by ICE... when he arrived at a USCIS office for a citizenship test. He is a green card holder. theintercept.com/2025/04/14/i...

The U.S. Department of Health and Human Services will remove gender dysphoria from disabilities protected under federal law. It’s unclear what the move means for a related lawsuit that could dismantle protections for all people with disabilities.

Among the abrupt termination of #CDC programs was the shuttering of the agency's viral #hepatitis lab. Imagine cops being asked to solve crimes without the capacity to test for fingerprints or swab for DNA. That's what this does to hepatitis surveillance in the US. www.statnews.com/2025/04/14/c...

More than half a dozen leaders of Native American groups used words like “cruel,” “disingenuous” and “offensive” to describe the proposed transfers. www.nytimes.com/2025/04/07/u...

New on @biopharmadive.com: Cancer biotech Tango Therapeutics laid off about 20% of its staff “in light of the extremely challenging financial markets,” CEO Barbara Weber confirmed to me. Last year, Tango cut two of its pipeline programs. www.biopharmadive.com/news/tango-t...

hey um, the National Weather Service is getting screwed. apparently tons of websites are set to go dark tonight because of lack of funds. Weather forecasters are saying this is going to affect warnings and predictions *immediately*

Labs at CDC investigating STD and hepatitis outbreaks have now been cut, as part of Secy Kennedy's layoffs Specimens were still arriving from state health departments, with no one left on job from labs to handle them "The outbreak detection is gone" www.cbsnews.com/news/rfk-jr-...

Let's talk about the first quarter in private #biosky cos. The megaround is here to stay, the IPO window is as shut as ever. The median funding round involving one of the roughly two dozen venture firms @biopharmadive.com tracks was worth $93M during 1Q25. www.biopharmadive.com/news/venture...

lots happening in the chaos with CDC, FDA, HHS firings this week - but one #biosky takeaway many are still reeling from is the departure of Peter Marks, a long-time champion for cell and gene therapy. from @benthefidler.bsky.social for @biopharmadive.com www.biopharmadive.com/news/peter-m...

Breaking: RFK Jr. has forced out PETER MARKS, the nation’s top vaccine regulator. In his resignation letter, obtained by the Post, Marks said he was willing to work with RFK Jr on his vaccine concerns — but said Kennedy wishes “subservient confirmation of his misinformation and lies.”

In a win for Verve Therapeutics, the #geneediting company announced today it got the OK from U.S. regulators to launch its clinical trial for a cholesterol-lowering treatment at home. From me for @biopharmadive.com #biosky www.biopharmadive.com/news/verve-u...

Alnylam's new heart drug Amvuttra is nearly twice the price of its pharmaceutical rivals'. Here's why, from @benthefidler.bsky.social www.biopharmadive.com/news/alnylam...

ICYMI, scoop @motherjones.com: HHS is requiring employees to return to offices where staff don't know if they'll have places to sit or office supplies But they won't be sending cancer researchers to an important annual conference next month, per an email I saw: www.motherjones.com/politics/202...

one of the most incredible negging PR tactics that will likely not land well with most health and biotech reporters

Thousands “Stand Up for Science” Across the Country Including Nobel laureates, climate researchers, and parents of kids saved by groundbreaking drugs. www.motherjones.com/politics/202...

hey so idk who at the white house needs to hear this, but transgender and transgenic are *NOT* the same thing